Mar 22, 2024, 07:46 AM by

Investment to bolster international partnerships and advance AI-driven solutions for antibody discovery

Mar 22, 2024, 06:00 AM by User Not Found

Bio-IT World | With the Bio-IT World Conference & Expo less than a month away, we are busy marking our schedules and planning our week. This year the event shifts a day, starting on Monday, and offers six deep-dive full day symposia on topics including automation, quantum computing, knowledge graphs, and more.

Mar 21, 2024, 07:57 AM by

Mar 21, 2024, 07:57 AM by

ReciBioPharm partners with GeneVentiv Therapeutics to advance first AAV-based gene therapy for haemophilia patients

Mar 21, 2024, 07:57 AM by

Mar 21, 2024, 07:57 AM by

Mar 21, 2024, 06:00 AM by User Not Found

Bio-IT World | But do different BME brands affect drug responses and gene expressions in organoids? To determine the answer, researchers at the Salk Institute tested out different BMEs to see their effects on pancreatic cancer organoids.

Mar 20, 2024, 08:31 AM by

Mar 20, 2024, 08:31 AM by

Mar 20, 2024, 08:31 AM by

Lindus Health Introduces Comprehensive “All-In-One CRO” Package for CNS, Neurology, and Psychiatric Clinical Trials

Mar 20, 2024, 08:31 AM by

Cambridge Healthtech Institute announces the final agenda for the inaugural Bio-IT World: Venture, Innovation & Partnering Conference—a gathering of leading investors, executives, research institutions, biotech and informatics innovators, startups, and strategics whose creative partnerships are catalyzing today’s drug discoveries. The April 17 Boston event, drawing heavily from leaders within the renowned Boston/Cambridge, Mass. biotech community, will be part of the 23rd annual Bio-IT World Conference & Expo April 15-17, which will attract more than 3,000 life science and IT innovators.

Mar 20, 2024, 08:31 AM by

DNAnexus is integrating new NVIDIA NIM and CUDA-X microservices to its Precision Health Data Cloud.

Mar 20, 2024, 08:31 AM by

The initiation of the phase I clinical trial for ABBV-1882 marks a significant milestone in the quest for novel HIV treatments. With its unique mechanism of action and potential to transform HIV management, ABBV-1882 represents a beacon of hope for individuals living with HIV and underscores AbbVie's unwavering commitment to advancing science for the benefit of patients worldwide.

Mar 20, 2024, 08:31 AM by

Mar 20, 2024, 08:31 AM by

Hunan Huateng Pharmaceutical Co., Ltd is set to present its groundbreaking solutions at CPHI Japan 2024, showcasing expertise in PEG derivatives and CDMO services. Attendees are encouraged to visit Booth No. 4X-08 to explore cutting-edge offerings and engage with industry experts.

Mar 20, 2024, 08:31 AM by

Biopharma PEG Scientific Inc. will showcase its latest high-purity polyethylene glycol (PEG) derivatives and custom synthesis solutions at Booth No. 718 in PEGS Boston Summit 2024 and at TIDES USA 2024 at Booth No. 935.

Mar 20, 2024, 08:31 AM by

Mar 19, 2024, 08:35 AM by

New facility includes 20KL of single use drug substance capacity coupled with drug product filling capacity of up to one million vials per day

Mar 19, 2024, 08:35 AM by

Life Sciences Industry Veteran to Lead Development and Execution of Growth and Innovation Strategy, Expanding Global Reach of Bioforum’s Biometric Services and Solutions

Mar 19, 2024, 08:35 AM by